Yayınlar & Eserler

Yayın Ağı
Makaleler 5
Tümü (5)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)

1. Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score

KUŞ F., GÜVEN D. C., YILDIRIM H. Ç., Chalabiyev E., Koc I., Tatar O. D., et al.
JOURNAL OF CLINICAL MEDICINE , sa.6, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors

KAVGACI G., GÜVEN D. C., KAYGUSUZ Y., KARACA E., DİZDAR Ö., Kilickap S., et al.
SUPPORTIVE CARE IN CANCER , cilt.32, sa.7, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study

KUŞ F., GÜVEN D. C., YILDIRIM H. Ç., Akagunduz B., Karakaya S., SÜTCÜOĞLU O., et al.
INTEGRATIVE CANCER THERAPIES , cilt.23, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

4. Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab

YILDIRIM H. Ç., KUŞ F., GÜVEN D. C., Karaca E., KAYGUSUZ Y., DİZDAR Ö., et al.
Journal of Immunotherapy and Precision Oncology , cilt.6, sa.4, ss.170-176, 2023 (Scopus) Creative Commons License identifier identifier identifier

5. KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer

KUŞ F., Guven D. C., YILDIRIM H. Ç., Chalabiyev E., AKYILDIZ A., Tatar O. D., et al.
Biomarkers in Medicine , cilt.17, sa.7, ss.379-389, 2023 (SCI-Expanded, Scopus) identifier identifier identifier
Metrikler

Yayın

5

Yayın (WoS)

5

Yayın (Scopus)

5

Proje

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları